Gainesville Eye Associates
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Gainesville Eye Associates sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Gainesville Eye Associates: 9 sponsored US clinical trials, 1 recruiting.
Gainesville Eye Associates sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 7 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataract and IOL Surgery, with 1 trials.
Top-decile sponsor footprint
Gainesville Eye Associates ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
9 total, page 1 of 1
HUD Surgical Guidance for Toric Alignment
NCT07325188
Clareon TruPlus vs Tecnis Eyhance IOLs in Cataract Patients
NCT07658040
Comparison of Visual Field Assessments Between Three Perimeters
NCT06539715
Comparison of Visual Outcomes With Mini-Monovision Between a Monofocal and an Adjustable Intraocular Lens
NCT06122103
Evaluation of Binocular Visual Acuity and Refractive Stability in the Alcon Clareon Intraocular Lens
NCT04936256
AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study
NCT04126187
Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes
NCT04126174
Evaluating Refractive and Visual Outcomes With the Alcon Toric ReSTOR +2.5 and +3.0 Models
NCT03856944
Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions
NCT02763124
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where Gainesville Eye Associates enrollment is open (later-stage tilt)
1 recruiting of 9 indexed (11% open); 7 completed (78%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Cataract and IOL Surgery (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Gainesville Eye Associates: open-pipeline peers nationwide
Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Gainesville Eye Associates sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 trials (± recruiting share)
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors near 11% open enrollment (± trial volume)
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
- Amylyx Pharmaceuticals · 11% recruiting · 9 trials
Related
What to do with this Gainesville Eye Associates page
9 registered trials is a research-attention snapshot, not an endorsement of Gainesville Eye Associates or any single study.
- 1 of Gainesville Eye Associates's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cataract and IOL Surgery is the condition Gainesville Eye Associates studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataract and IOL Surgery trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Gainesville Eye Associates pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.